Australia is closely watching the arrival of retatrutide, a novel dual GIP and GLP-1 receptor agonist , representing a potential advance in weight loss . Early study data have demonstrated impressive results, https://giant-escape-bike242256.blgwiki.com/2681922/emerging_medication_in_australia_a_promising_solution_for_reducing_body_weight